DAY 1
December 8, 2022
THURSDAY8:30-9:30
R E G I S T R A T I O N
| TIME | TOPIC | SPEAKER |
| 9.30 – 9.40 | Welcome address | Prof. Maqsood Siddiqi, President, APOCP and Founder-Chairman, Cancer Foundation of India |
| 9.40 – 9.55 | Inaugural Lecture | Dr. Soumya Swaminathan Chief Scientist, WHO, (Virtual) Cancer Research in LMICs |
| 9.55 – 10.15 | Guest Lecture 1
| Dr. R. Sankaranarayanan Ex-IARC, France Making cancer healthcare affordable: the need of the hour |
| 10.15 – 10.35 | Guest Lecture 2
| Prof. Anil D’Cruz President, UICC To Be Decided |
| 10.35 – 11.00 | Keynote address | Dr. Elisabete Weiderpass (Virtual) Director, IARC, Lyon IARC activities and initiatives in Asia-Pacific region |
11.00 - 11:30 Tea & Coffee Break
Session 1:
Cervical Cancer – Screening, Early detection & Treatment
Chairs:
Radhika Srinivasan, PGIMER, Chandigarh, India
Neerja Bhatla, AIIMS, New Delhi, India
11.30 – 13.00
15 mins : Plenary 1. Lynette Denny, Univ Cape Town, South Africa
Screen and treat – will this approach realistically reduce cervical cancer incidence in low resource settings?
Screen and treat – will this approach realistically reduce cervical cancer incidence in low resource settings?
15 mins : Plenary 2. Karen Canfell, The University of Sydney, Sydney, Australia
The interaction between HPV vaccination and cervical screening: how does vaccination change the way we think about screening?
The interaction between HPV vaccination and cervical screening: how does vaccination change the way we think about screening?
15 mins : Plenary 3. Gultekin Murat, Hacettepe Univ. Ankara, Turkey (virtual)
HPV DNA Screening Up to Date Evidence and Mega HPV Labs
HPV DNA Screening Up to Date Evidence and Mega HPV Labs
10 mins : Sagarika Rout, ICMR National Institute of Cancer Prevention and Research, Noida, India
Association of genital infections as early symptoms of cervical cancer among women tobacco users in India
Association of genital infections as early symptoms of cervical cancer among women tobacco users in India
10 mins : Farhin Sultana, Chittaranjan National Cancer Institute, Kolkata, India
LIMD1 targeting miR-135b-5pas biomarker for non-invasive Detection of clinically relevant preneoplastic cervical lesions
LIMD1 targeting miR-135b-5pas biomarker for non-invasive Detection of clinically relevant preneoplastic cervical lesions
10 mins : Asima Mukhopadhyay, Cepheid India Private Limited
Point of Care NAT testing for HPV DNA
Point of Care NAT testing for HPV DNA
10 mins : Mel Kohn, Executive Director, Medical Affairs – Vaccines, MSD, US
The Nanovalent HPV vaccine
The Nanovalent HPV vaccine
Q & A
13.00 - 14:00 Lunch Break
Session 2:
HPV vaccination and Prevention of Cervical Cancer
Chairs:
R. Sankaranarayanan, Former Head of the Screening group, International Agency for Cancer Research, Lyon, France
Bhudev C. Das, Chairman, Amity Institute of Mol. Med. & Stem Cell Research., Noida, India
14.00 – 15.30
15 mins : Plenary 4. Peter Sasieni, King’s College, London University, UK
Impact of HPV vaccination on cervical cancer incidence
Impact of HPV vaccination on cervical cancer incidence
15 mins : Plenary 5. Partha Basu, IARC, France
Single dose recommendation for HPV vaccine – a game changer
Single dose recommendation for HPV vaccine – a game changer
15 mins :Plenary 6. Gary M Clifford, IARC, France
Infection-attributable cancer burden in Asia Pacific: a focus for prevention
Infection-attributable cancer burden in Asia Pacific: a focus for prevention
10 mins : Abhisikta Ghosh, National Institute of Biomedical Genomics, Kalyani, India
Identification of molecular immune subtypes of HPV16 positive cervical cancers, with divergent oncogenic phenotypes, in relation to host and viral factors
Identification of molecular immune subtypes of HPV16 positive cervical cancers, with divergent oncogenic phenotypes, in relation to host and viral factors
10 mins : Ritu Aggarwal, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Understanding the tissue microRNA expression profile as markers of progression in HPV infected cervix
Understanding the tissue microRNA expression profile as markers of progression in HPV infected cervix
10 mins : Shivani Desai, Serum Institute, Pune
Changing the HPV landscape with indigenous vaccine – CERVAVAC
Changing the HPV landscape with indigenous vaccine – CERVAVAC
Q & A
15.30 - 16:00 Tea & Coffee Break
Session 3:
Cancer incidence in Asia Pacific region
Chairs:
Prakash C Gupta, Healis Inst Pub Health, Navi Mumbai, India
Alireza Mosavi-Jarrahi, Shahid Beheshti Univ. Med Sc., Tehran, Iran
16.00– 17.30
15 mins :Plenary 7. Manami Inoue, Nat Cancer Centre, Tokyo, Japan
Epidemiology of Diabetes and the risk of Cancer
Epidemiology of Diabetes and the risk of Cancer
15 mins : Plenary 8. Prashant Mathur, ICMR-NCDIR, Bangalore, India
Cancer surveillance in India: Role of National Cancer Registry Program
Cancer surveillance in India: Role of National Cancer Registry Program
15 mins : Plenary 9. Shalini Singh, ICMR-NICPR, Noida, India (Virtual)
Smokeless Tobacco Use among women: a neglected issue
Smokeless Tobacco Use among women: a neglected issue
10 mins : Shubhi Goel, Post-Graduate Institute of Dental Sciences, Rohtak, Haryana, India
Evidence mapping of Incidence, prevalence, and trends of oral cancer across the Nation
Evidence mapping of Incidence, prevalence, and trends of oral cancer across the Nation
10 mins : Sonam Tulsyan, ICMR National Institute of Cancer Prevention and Research, Noida, India
Somatic Mutational Landscape of Gallbladder Cancer in North Indian Population
Somatic Mutational Landscape of Gallbladder Cancer in North Indian Population
10 mins : Bobby Paul , All India Institute of Hygiene and Public Health, &
Cancer Foundation of India, Kolkata, India
Barriers to Cancer Screening uptake under NPCDCS programme in Northeast India: Formative research results
Barriers to Cancer Screening uptake under NPCDCS programme in Northeast India: Formative research results
Q & A
17.30 - Sessions CLOSE
17.30–18.30 - APOCP Executive Meet
19.30 – 21.00 - WELCOME DINNER - Plenary Speakers/Invited Guests
DAY 2
December 9, 2022
FRIDAYSession 4:
Cancer Risk Factors and Prevention
Chairs:
Rajesh N Sharan, Former Professor, Department of Biochemistry, NEHU,Shillong, Meghalaya, India
Sharmila Sengupta, NIBG, Kalyani, India
9.30 – 11.00
15 mins : Plenary 10. Saeid Doaei, Shahid Beheshti University of Medical Sciences, Tehran, Iran
The interactions between cancer, lifestyle, and the FTO gene
The interactions between cancer, lifestyle, and the FTO gene
15 mins : Plenary 11. Prakash C. Gupta, Healis Inst Pub Health, Navi Mumbai, India
Burden of Tobacco and Related Cancers in India
Burden of Tobacco and Related Cancers in India
15 mins : Plenary 12. Sharmila Sengupta, NIBG, Kalyani, India
HPV-based cervical cancer screening: transition from cross-sectional to a longitudinal approach
HPV-based cervical cancer screening: transition from cross-sectional to a longitudinal approach
10 mins : Sujata Pathak, All India Institute of Medical Sciences, New Delhi, India
Association between one-carbon metabolites and risk of cervical cancer
Association between one-carbon metabolites and risk of cervical cancer
10 mins : Dona Sinha Chittaranjan National Cancer Institute, Kolkata, India
Environmental Risk for Pro-carcinogenic Alteration in Pulmonary and Systemic Micro-environments of Exposed Population
Environmental Risk for Pro-carcinogenic Alteration in Pulmonary and Systemic Micro-environments of Exposed Population
10 mins : Isha Joshi, ICMR National Institute of Cancer Prevention and Research, Noida, India
Association between Second-hand smoke exposure and neonatal mortality in India
Association between Second-hand smoke exposure and neonatal mortality in India
10 mins : Ananth Ponneri Babuharisankar,National Health Research Institute, Miaoli, Taiwan
Mitochondrial Lon interacts with ULK1-FUNDC1 at the ER-mitochondria interface to promote the mitophagy under hypoxia
Mitochondrial Lon interacts with ULK1-FUNDC1 at the ER-mitochondria interface to promote the mitophagy under hypoxia
Q & A
11.00 - 11:30 Tea & Coffee Break
11:30 - 12:15 General Assembly of APOCP (for APOCP members only)
11:30 - 12:15 Attend Poster Session
Session 5:
Panel Discussion
12.15– 13.00
Topic: “WHO call for the elimination of cervical cancer, its challenges, and way forward in Low- and middle-income countries.”
Neerja Bhatla (Moderator), AIIMS, India
Karen Canfell, The Univ. of Sydney, Australia
Meenu Anand, American Cancer Society, USA,
Sharmila Pimple, TMH, Mumbai, India
Partha Basu, IARC, France
Karen Canfell, The Univ. of Sydney, Australia
Meenu Anand, American Cancer Society, USA,
Sharmila Pimple, TMH, Mumbai, India
Partha Basu, IARC, France
13.00 - 14:00 Lunch Break
Session 6:
Breast Cancer Control – Strategy & Policy
Chairs:
K. Ramdas, Karkinos Heathcare, Thiruvananthapuram, India
Jayanta Chakravarty, CNCI, Kolkata, India
14.00 – 15.30
15 mins : Plenary 13. Benjamin O. Anderson, Univ Washington, USA & WHO (Virtual)
WHO Global Breast Cancer Initiative (GBCI) (Virtual)
.
WHO Global Breast Cancer Initiative (GBCI) (Virtual)
.
15 mins : Plenary 14. .K. Ramdas, Karkinos Heathcare, Thiruvananthapuram, India
Breast cancer prevention – Current Status
Breast cancer prevention – Current Status
15 mins : Plenary 15. Shruti Shukla, Open Health System Labs., USA
The Breast Cancer Data Alliance
The Breast Cancer Data Alliance
10 mins : Susmita Mondal, Presidency University, Kolkata, India
PFKFB3: A new prognostic marker in Triple-negative breast invasive ductal carcinoma
PFKFB3: A new prognostic marker in Triple-negative breast invasive ductal carcinoma
10 mins : Maryam Gholamalizadeh, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Relationship between Breast Cancer and Dietary Inflammatory Index
Relationship between Breast Cancer and Dietary Inflammatory Index
10 mins : Debparna Nandy, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
Role of histone epigenetic players in breast cancer
Role of histone epigenetic players in breast cancer
10 mins : Geetha Manjunath, Niramai Health Analytix Pvt. Ltd
Clinical evaluation of Thermalytix, an affordable, portable, radiation-free breast cancer screening device powered by Artificial Intelligence
Clinical evaluation of Thermalytix, an affordable, portable, radiation-free breast cancer screening device powered by Artificial Intelligence
Q & A
15.30 - 16:00 Tea & Coffee Break
Session 7:
Breast Cancer Control –Risk Factors and Intervention
Chairs:
Abhishek Shankar, AIIMS, Patna, India
Shruti Shukla, Open Health System Labs., USA
16.00 – 17.30
15 mins : Plenary 16. Nurbek Igissinov, Cent Asian Cancer Inst, Astana, Kazakhstan
Breast Cancer in Kazakhstan
Breast Cancer in Kazakhstan
15 mins : Plenary 17. Richard Muwonge, IARC, Lyon
Effectiveness of triennial screening with clinical breast examination – 14-years follow-up outcomes of randomized clinical trial in Trivandrum, India
Effectiveness of triennial screening with clinical breast examination – 14-years follow-up outcomes of randomized clinical trial in Trivandrum, India
15 mins : Plenary 18. Keun-Young Yoo, Seoul Nat Univ Coll Med, South Korea (Virtual)
Breast Cancer Screening - National Cancer Control Strategy in Korea
Breast Cancer Screening - National Cancer Control Strategy in Korea
10 mins : Khushboo Sinha, Academy of Scientific and Innovative Research, CSIR-CDRI campus, Lucknow, India
Identification of molecular signatures for the diagnosis and prognosis of Triple Negative Breast Cancers (TNBCs)
Identification of molecular signatures for the diagnosis and prognosis of Triple Negative Breast Cancers (TNBCs)
10 mins : Ranjana Pal, Presidency University, Kolkata, India
CDH1 Protein Plays a Crucial Role in Regulating TRAIL Resistance in Breast Cancer
CDH1 Protein Plays a Crucial Role in Regulating TRAIL Resistance in Breast Cancer
10 mins : Stuti Roy, Saroj Gupta Cancer Centre and Research Institute, Kolkata, India
The CUEDC2-ERα Molecular Interplay- A New Insight into Mitotic Regulation Influencing Clinical Outcome in Breast Cancer
The CUEDC2-ERα Molecular Interplay- A New Insight into Mitotic Regulation Influencing Clinical Outcome in Breast Cancer
10 mins : Arunima Biswas, University of Kalyani, Kalyani, India
Role of Phosphodiesterase 4 Inhibitor Rolipram in Regressing Breast Cancer by Modulating Hedgehog Signaling Downstream of Smoothened through Gli Ubiquitination
Role of Phosphodiesterase 4 Inhibitor Rolipram in Regressing Breast Cancer by Modulating Hedgehog Signaling Downstream of Smoothened through Gli Ubiquitination
Q & A
Session Close 17:30
DAY 3
December 10, 2022
SATURDAYGuest Lecture 09:10 To 09:30
Session 8:
Translational Research in Cancer
Chairs:
Sharmila Sengupta, NIBG, Kalyani, India
Susanta Roychoudhury, IICB, Kolkata, India
9.30 – 11.00
15 mins : Plenary 19. Chinmay Kumar Panda, CNCI, Kolkata, India
Anti-tumor activities of some natural phenolic compounds
Anti-tumor activities of some natural phenolic compounds
15 mins : Plenary 20. Mausumi Bharadwaj, ICMR-NICPR, Noida, India
Oral Microbiome among Smokeless Tobacco (SLT) users: A metagenomic approach for identification of Carcinogenic Potential
Oral Microbiome among Smokeless Tobacco (SLT) users: A metagenomic approach for identification of Carcinogenic Potential
15 mins : Plenary 21. Ranajit Mondal, CNCI, Kolkata, India
Time Trends of HPV prevalence over last two Decades - CNCI experience
Time Trends of HPV prevalence over last two Decades - CNCI experience
10 mins : Md Sadi Khan, Chittaranjan National Cancer Institute, Kolkata, India
Dysregulated transcriptome identification from HNSCC samples and their clinical implications
Dysregulated transcriptome identification from HNSCC samples and their clinical implications
10 mins : Juhina Das, Chittaranjan National Cancer Institute, Kolkata, India
NLGP is effective to delay 4NQO mediated initiation-promotion cascade in tongue squamous cell carcinogenesis of Swiss mice by maintaining type 1 immune polarity
NLGP is effective to delay 4NQO mediated initiation-promotion cascade in tongue squamous cell carcinogenesis of Swiss mice by maintaining type 1 immune polarity
10 mins : Pritha Roy Choudhury, Chittaranjan National Cancer Institute, Kolkata, India
Prolonged statin treatment in hypercholesterolemic mice promotes tumour progression by affecting the dendritic cell-mediated antigen presentation pathway.
Prolonged statin treatment in hypercholesterolemic mice promotes tumour progression by affecting the dendritic cell-mediated antigen presentation pathway.
10 mins : Upma Sharma, ICMR National Institute of Cancer Prevention and Research, Noida, India
Genetic variations in the IL-10 gene associated with over expression of immunosuppressive cytokine and oral cancer risk
Genetic variations in the IL-10 gene associated with over expression of immunosuppressive cytokine and oral cancer risk
Q & A
11.00 - 11:30 Tea & Coffee Break
Session 9:
Novel Approaches for Cancer Prevention and Management
Chairs:
Rita Mulhelkar, Former Head, Genetic Engg, ACTREC, Navi Mumbai, India
Rathindranath Baral,CNCI, Kolkata, India
11.30 – 13.00
15 mins : Plenary 22. Tanuja Nesari, All India Inst of Ayurveda, New Delhi, India (Virtual)
Role of Ayurveda in prevention, treatment, and management of cancer
Role of Ayurveda in prevention, treatment, and management of cancer
15 mins : Plenary 23. KV Subba Rao, Predomix, Gurgaon, India
Metabolomics-based Platform for Early Detection of Multiple Cancers
Metabolomics-based Platform for Early Detection of Multiple Cancers
15 mins : Plenary 24. Urmi Chatterji, University of Calcutta, Kolkata, India
Targeting the smarter cells: a paradigm shift for cancer therapy
Targeting the smarter cells: a paradigm shift for cancer therapy
10 mins : Mohona Chakravarti, Chittaranjan National Cancer Institute, Kolkata, India
PD1-Therapy-Resistant Terminally Exhausted CD8+TILs Advances Expansion of Aggressive Cancer Stem Cells in Breast, Ovarian and Cervical Carcinoma patients
PD1-Therapy-Resistant Terminally Exhausted CD8+TILs Advances Expansion of Aggressive Cancer Stem Cells in Breast, Ovarian and Cervical Carcinoma patients
10 mins : Syed Musthapa Meeran, CSIR Central Food Technological Research Institute, Mysore, India
Epi-diet alters the homeostasis of the gut microbiome for the management of cancer therapy
Epi-diet alters the homeostasis of the gut microbiome for the management of cancer therapy
10 mins : Renaissa De, Department of Biophysics, PGIMER, Chandigarh, India
Autophagic regulation of hedgehog pathway in cervical cancer stem cells
Autophagic regulation of hedgehog pathway in cervical cancer stem cells
10 mins : Vaishnave S, Cancer Institute (WIA), Adyar, Chennai, India
Exploring the potential of autoantibodies as a diagnostic and prognostic biomarker for gynecological cancer
Exploring the potential of autoantibodies as a diagnostic and prognostic biomarker for gynecological cancer
Q & A:
13.00 - 14:00 Lunch
Session 10:
Interdisciplinary Research in Cancer Prevention
Chairs:
Mausumi Bharadwaj, Scientist, ICMR-NICPR, Noida, UP, India
Sanghamitra Sengupta, Professor, Biochemistry, Univ of Calcutta, Kolkata, India
Rajesh N Sharan, Former Head of Biochemistry , NEHU, Shillong, India
14.00 – 15.30
10 mins : Salini Das, Chittaranjan National Cancer Institute, Kolkata, India
Aspirin down-regulates G2/M effectors to evoke mitotic catastrophe in radio-resistant cervical cells
Aspirin down-regulates G2/M effectors to evoke mitotic catastrophe in radio-resistant cervical cells
10 mins : Ratsada Praphasawat, Department of Pathology, School of Medicine, University of Phayao, Thailand
Evaluation of cytotoxicity and efficacy of red rice bran extract on apoptosis induction in colorectal cancer cells
Evaluation of cytotoxicity and efficacy of red rice bran extract on apoptosis induction in colorectal cancer cells
10 mins : Mogana Das Murtey, University Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
Paddy waste suppresses benign prostate hyperplasia in spontaneously hypertensive rats (SHR) model by inducing chemopreventive effects
Paddy waste suppresses benign prostate hyperplasia in spontaneously hypertensive rats (SHR) model by inducing chemopreventive effects
10 mins : Ranodeep Chatterjee, Department of Zoology, University of Calcutta, Kolkata, India
Effect of Artemisinin in modulation of CLEC12A: A novel target for cancer therapy
Effect of Artemisinin in modulation of CLEC12A: A novel target for cancer therapy
10 mins : Rohit Siddhartha, Department of Biochemistry, University of Lucknow, Lucknow, India
CD105, a novel marker of diagnosis and prognosis in non-muscle invasive and muscle invasive urothelial carcinoma of bladder patients
CD105, a novel marker of diagnosis and prognosis in non-muscle invasive and muscle invasive urothelial carcinoma of bladder patients
10 mins : Tanusree Ray, ICMR- National Institute of Cholera & Enteric Diseases, Kolkata, India
Vibrio cholerae hemmagglutinin protease: A novel microtubule targeting agent to kill colon cancer cells by triggering multiple cellular proteases and proteasomal cascades and induced apoptosis in explant culture of human clinical samples
Vibrio cholerae hemmagglutinin protease: A novel microtubule targeting agent to kill colon cancer cells by triggering multiple cellular proteases and proteasomal cascades and induced apoptosis in explant culture of human clinical samples
10 mins : Sukanya Ghosh, Chittaranjan National Cancer Institute, Kolkata,
India
Particulate Matter 2.5 Augments pro-oncogenic drivers PI3K/AKT in exposed urban population of Kolkata
Particulate Matter 2.5 Augments pro-oncogenic drivers PI3K/AKT in exposed urban population of Kolkata
10 mins : Nilanjana Basu, Amity University, NOIDA, India
Integration of in vitro and in silico perspectives to explain the anticancer effect of Arnica Montana
Integration of in vitro and in silico perspectives to explain the anticancer effect of Arnica Montana